American Well Corporation (NYSE:AMWL) Receives Consensus Rating of "Hold" from Analysts

Key Points

• American Well Corporation (NYSE:AMWL) has received a consensus rating of "Hold" from seven analysts, with one issuing a buy rating, and an average price target of $9.17.
• Wells Fargo reduced its price target for American Well from $15.00 to $12.00 while maintaining an "overweight" rating.
• Insider trading activity has been notable, with insiders selling a total of 49,381 shares valued at $344,830 in the last ninety days.

American Well Corporation (NYSE:AMWL - Get Free Report) has been assigned an average rating of "Hold" from the seven analysts that are presently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $9.1667.

Separately, Wells Fargo & Company cut their price objective on shares of American Well from $15.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th.

Insider Activity

In related news, insider Dmitry Zamansky sold 25,605 shares of the business's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $6.77, for a total value of $173,345.85. Following the completion of the transaction, the insider directly owned 197,711 shares in the company, valued at $1,338,503.47. The trade was a 11.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Phyllis Gotlib sold 4,781 shares of the company's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $6.78, for a total transaction of $32,415.18. Following the transaction, the insider owned 132,110 shares of the company's stock, valued at $895,705.80. This represents a 3.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 49,381 shares of company stock valued at $344,830 in the last ninety days. Insiders own 11.82% of the company's stock.

Institutional Investors Weigh In On American Well

A number of hedge funds have recently modified their holdings of the company. Northern Trust Corp boosted its stake in American Well by 7.4% during the fourth quarter. Northern Trust Corp now owns 29,021 shares of the company's stock worth $210,000 after buying an additional 1,992 shares during the period. Jane Street Group LLC raised its holdings in American Well by 21.9% during the fourth quarter. Jane Street Group LLC now owns 19,260 shares of the company's stock worth $140,000 after purchasing an additional 3,462 shares in the last quarter. Two Sigma Advisers LP grew its position in shares of American Well by 102.7% during the fourth quarter. Two Sigma Advisers LP now owns 41,045 shares of the company's stock worth $298,000 after acquiring an additional 20,800 shares during the last quarter. Two Sigma Investments LP grew its position in shares of American Well by 12.3% during the fourth quarter. Two Sigma Investments LP now owns 19,216 shares of the company's stock worth $139,000 after acquiring an additional 2,102 shares during the last quarter. Finally, Sapient Capital LLC purchased a new position in American Well in the 1st quarter valued at $79,000. Hedge funds and other institutional investors own 56.05% of the company's stock.

American Well Stock Performance

AMWL opened at $6.19 on Friday. The stock has a market capitalization of $99.90 million, a price-to-earnings ratio of -0.77 and a beta of 1.27. The company has a fifty day moving average of $7.15 and a 200 day moving average of $7.34. American Well has a fifty-two week low of $6.09 and a fifty-two week high of $12.95.

American Well (NYSE:AMWL - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($1.24) EPS for the quarter, topping analysts' consensus estimates of ($1.84) by $0.60. American Well had a negative net margin of 46.15% and a negative return on equity of 41.99%. The business had revenue of $70.90 million during the quarter, compared to analysts' expectations of $63.87 million. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts forecast that American Well will post -9.34 earnings per share for the current year.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.